Mr GH, a 52-year-old patient with hypertension, first presented aged 42, with weakness of his right arm and leg which had developed suddenly. Examination showed signs of a right hemiparesis and a blood pressure of 230/125 mm Hg, and antihypertensive treatment with methyldopa was started. Apart from a syncopal attack three years ago (which was ascribed to postural hypotension) he has been otherwise well and made a complete recovery from his "stroke." For the past three months, however, he has complained of classical symptoms of intermittent claudication of his right leg, which now limits his exercise capacity to 100 yards. In addition, he has noticed tingling of his right hand and palm lasting five to 10 minutes at a time and recurring almost every day: moreover, he has also had short periods (four to five minutes) of involuntary movement of his right wrist occurring independently ofhis sensory symptoms. He is currently receiving methyldopa 250 mg twice daily, and hydrochlorothiazide, 50 mg every morning. His I would continue hydrochlorthiazide but I would suggest you transfer him to a beta-blocker such as propranolol, starting at a dose of 40 mg thrice daily and increasing it in the light of the clinical response. This is for two reasons: firstly, hypotensive control with beta-blockers usually has fewer adverse effects than with methyldopa and, secondly, because beta-blockade appears to prevent "sudden death" in the secondary prevention of myocardial infarction.
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Patients vary in their dosage requirements of propranolol probably for two reasons: firstly, a large fraction of an oral dose of propranolol is removed by the liver before it ever reaches the systemic circulation, and this fraction varies between individuals; and, secondly, individuals vary in their response to the drug even at the same plasma concentration, possibly dependent on their plasma renin activity. There is therefore no substitute for careful dosage titration against the response.
It is easy to give patients a supply of drugs, tell them to come back when they are running low, and then forget all about them. One system is to give the patient a card saying "your next appointment is . . ." and at the same time enter it in the appointments book.
Postscript
On a combination of hydrochlorothiazide (50 mg once daily) and propranolol (160 mg three times a day) Mr GH's blood pressure stabilised at 130-140/85-95 
